Agilent Technologies Inc.

Most Recent

  • uploads///MFA Financial
    Financials

    MFA Financial portfolio yield continues to drop

    MFA Financial is a REIT that invests in both agency and non-agency mortgage backed securities MFA Financial (MFA) is a mortgage Real Estate Investment Trust (REIT) that invests in both agency (government guaranteed) and non-agency (non-guaranteed) mortgage backed securities. Their portfolio is primarily invested in hybrids, adjustable rate mortgages (ARM), and 15 year fixed rate […]

    By Brent Nyitray, CFA, MBA
  • uploads///Sovereign Yields
    Financials

    Is it something Bernanke said? Or something else?

    Sovereign yields have been rising since the beginning of May Investors in the U.S. have been focused on the rising yield of the 10-year bond since the beginning of May. Since bottoming out at 1.63% on May 1st, the U.S. 10-year yield has been rising in a dramatic fashion, to close at 2.17% as of […]

    By Brent Nyitray, CFA, MBA
  • uploads///Fed Unemployment Forecast
    Financials

    Federal Reserve significantly lowers unemployment forecast

    The Federal Reserve includes formal economic forecasts in the minutes from its Federal Open Market Committee (FOMC) Meetings The Federal Reserve typically releases a short press release after its two day FOMC meeting, with a general overview and its decision on interest rates. A month later, they release the actual minutes of the meeting which […]

    By Brent Nyitray, CFA, MBA
  • uploads///pershing
    Fund Managers

    Ackman’s Pershing Square Increased Agilent Stake in Q3

    This week, Pershing Square disclosed that it had increased its stake in Agilent Technologies (A) to 2.9 million shares in the third quarter.

    By Rabindra Samanta
  • uploads///MTW
    Industrials

    Relational Investors goes activist on Manitowoc

    Relational Investors LLC was co-founded by Ralph Whitworth and David Batchelder. It filed a 13D with the SEC last week and said it acquired 11.5 million shares, or an 8.52% stake, in Manitowoc (MTW)

    By Samantha Nielson
  • uploads///RMD ana reco
    Company & Industry Overviews

    What ResMed’s Valuation Trend Indicates

    The mean rating for ResMed (RMD) stock is 2.6, and its target price is $104.69.

    By Kenneth Smith
  • uploads///A ana reco
    Company & Industry Overviews

    What’s the Upside Potential for Agilent Technologies Stock?

    In the last three months, Agilent Technologies (A) stock has risen from $61.14 on June 27, 2018, to $70.33 in September 2018.

    By Kenneth Smith
  • uploads///A
    Company & Industry Overviews

    What’s Driving Agilent Technologies’ Segment Growth?

    Agilent Technologies’ (A) Life Sciences and Applied Markets segment had revenues of $510 million in Q3 2017 compared to $540 million in Q3 2018.

    By Kenneth Smith
  • uploads///molecule _
    Company & Industry Overviews

    Agilent Technologies: Its Acquisition Spree in 2018

    Agilent Technologies (A) has been on an acquisition spree in 2018 with major acquisitions made until the third quarter.

    By Kenneth Smith
  • uploads///chemist _
    Company & Industry Overviews

    How Thermo Fisher Scientific’s Valuation Looks in September

    Thermo Fisher Scientific currently trades at a forward PE multiple of ~19.9x.

    By Mike Benson
  • uploads///war _
    Basic Materials

    Metal Stocks Brace for Tough Times as Trade War Intensifies

    Equity markets closed deep in the red yesterday. Looking at the broader-market ETFs, we see that the SPDR S&P 500 ETF (SPY) lost 1.36%, shrinking its year-to-date (or YTD) losses to 2.4%.

    By Mohit Oberoi, CFA
  • uploads///digital science capabilities
    Company & Industry Overviews

    Thermo Fisher Scientific’s Deepening Ties with Sema4

    Thermo Fisher Scientific’s (TMO) Core Informatics’ Platform for Science’s modules, including a LIMS (laboratory information management system), could soon be implemented at Sema4’s two major laboratory facilities.

    By Sarah Collins
  • uploads///GENETIC ANALYSIS GROWTH STRATEGY
    Company & Industry Overviews

    TMO’s Launch of New Research Assay for Cancer

    On December 7, 2017, Thermo Fisher Scientific announced the launch of a new targeted NGS (next-generation sequencing) research panel.

    By Sarah Collins
  • uploads///A
    Healthcare

    Agilent Technologies’ Downward Sloping Dividend Yield Curve

    Agilent Technologies’ net revenue rose 6.0% in the first nine months of 2017, driven by every segment. Income from operations rose 41.0% as total costs didn’t increase much.

    By Amanda Lawrence
  • uploads///life sciences group
    Company & Industry Overviews

    Thermo Fisher Scientific Accelerates Its Semiconductor Sequencing

    On June 29, 2017, Thermo Fisher Scientific (TMO) announced the addition of three new products to its semiconductor failure analysis workflows portfolio.

    By Sarah Collins
  • uploads///innovation
    Company & Industry Overviews

    Understanding Thermo Fisher’s Growth Strategy

    Thermo Fisher Scientific (TMO) has always focused on innovation as a key growth strategy.

    By Sarah Collins
  • uploads///tho pm
    Basic Materials

    Northcoast Research Upgrades Thor Industries to a ‘Buy’

    Thor Industries (THO) has a market cap of $4.3 billion. It rose 0.06% to close at $77.21 per share on September 13, 2016.

    By Gabriel Kane
  • uploads///reveneus
    Company & Industry Overviews

    Thermo Fisher Scientific’s Key Growth Strategy

    Thermo Fisher Scientific reported ~$4.5 billion in revenues in 2Q16, representing YoY (year-over-year) growth of ~6%.

    By Sarah Collins
  • uploads///innovation
    Company & Industry Overviews

    How Innovation Is Driving Thermo Fisher Scientific’s Growth

    Thermo Fisher Scientific now has more than 800,000 products in its portfolio and has an extensive product pipeline.

    By Sarah Collins
  • uploads///segmentation
    Company & Industry Overviews

    An Overview of Thermo Fisher Scientific’s Business Model

    Thermo Fisher Scientific (TMO) has made a number of acquisitions over the years, resulting in the expansion of the company’s product portfolio with the inclusion of a number of premium brands.

    By Sarah Collins
  • uploads///Revs distri for DIS in FY
    Earnings Report

    Disney’s Business Segments: Expectations for Fiscal 2016

    Disney’s Media Networks segment was the biggest contributor to its revenue at 44% with segment revenues of $23.3 billion in fiscal 2015.

    By Shirley Pelts
  • uploads///analytical instruments segmentation
    Company & Industry Overviews

    Thermo Fisher Scientific’s Analytical Instruments Business Segment

    Thermo Fisher Scientific’s Analytical Instruments segment earned revenues of ~$3.3 billion in 2014, representing organic growth of around 4%.

    By Sarah Collins
  • uploads///life sciences solutions
    Company & Industry Overviews

    The Life Sciences Solutions Segment of Thermo Fisher Scientific

    Thermo Fisher Scientific’s Life Sciences Solutions segment earned revenues of ~$4.2 billion in 2014, representing organic growth of around 4%.

    By Sarah Collins
  • uploads///revenue
    Company & Industry Overviews

    Thermo Fisher Scientific: A Leading Medical Technology Company

    Thermo Fisher Scientific (TMO) is one of the leading medical technology companies in the world, providing a broad portfolio of laboratory equipment and services.

    By Sarah Collins
  • uploads///
    Fund Managers

    Is Teradyne fairly valued relative to its peers?

    Presently, ten analysts have given Teradyne a buy rating, and four have issued a neutral rating, for a consensus target price of $22.17.

    By Santiago Solari
  • uploads///
    Fund Managers

    Teradyne’s momentum may translate to strong full-year results

    Teradyne is set to have 15% year-over-year growth in sales to $1.6 billion in 2014. This growth is driven by share gains in the SoC and memory test markets.

    By Santiago Solari
  • uploads///
    Fund Managers

    Teradyne boasts encouraging market share gains

    Teradyne has about 26% share of the $470-million memory testing market. The company expects to gain 3 to 5 points of share this year.

    By Santiago Solari
  • uploads///
    Fund Managers

    A key analysis of Teradyne’s revenues and earnings

    In 2013, Teradyne survived a weak demand climate for the app processor market. The company’s revenues recovered due to strong SoC product volume growth.

    By Santiago Solari
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.